19220

    543998

    VALIANTLAB

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    VALIANT LABORATORIES LTD Share Price Today

    VALIANT LABORATORIES LTD is currently trading at ₹63.75, up by ₹1.66 from the previous close. The stock touched an intraday high of ₹64.25 and a low of ₹60.16 during the latest trading session. Over the past one year, VALIANT LABORATORIES LTD has delivered a loss of 40.85%, while the stock has declined 10.26% in the last one month.

    VALIANT LABORATORIES LTD performance

    Today’s low Today’s high
    ₹ 60.16 ₹ 64.25
    ₹ 63.75
    52 week low 52 week high
    ₹ 49.51 ₹ 115.05
    ₹ 63.75
    Open Price ₹ 62.08
    Prev. Close ₹ 62.08
    Volume (Shares) 9613.00
    Total traded value ₹ 6.12
    Upper Circuit ₹ 65.18
    Lower Circuit ₹ 58.98
    info

    Investment Returns

    Over 1 Month -10.26% Over 3 Months 6.33% Over 6 Months -4.66% Over 1 Year -40.85%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    VALIANT LABORATORIES LTD fundamentals


    • Market cap (Cr) 346.20
    • P/E Ratio (TTM) 61.00
    • Beta 0.89
    • Book Value / share 58.87
    • Return on equity -1.40%
    • EPS (TTM) 1.02
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 3.53
    info icon alternate text
    • Market cap (Cr) 342.20
    • P/E Ratio (TTM) 61.00
    • Beta 0.95
    • Book Value / share 58.87
    • Return on equity -1.40%
    • EPS (TTM) 1.02
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 3.53
    info icon alternate text

    VALIANT LABORATORIES LTD Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 65.30
    Operating Expense 61.34
    Net Profit 3.53
    Net Profit Margin (%) 5.40
    Earnings Per Share (EPS) 0.65
    EBITDA 5.27
    Effective Tax Rate (%) 25.36
    Particulars DEC 2025 (Values in Cr)
    Revenue 54.74
    Operating Expense 55.24
    Net Profit 0.03
    Net Profit Margin (%) 0.05
    Earnings Per Share (EPS) 0.01
    EBITDA 0.86
    Effective Tax Rate (%) 72.72
    Particulars SEP 2025 (Values in Cr)
    Revenue 45.99
    Operating Expense 46.58
    Net Profit 0.17
    Net Profit Margin (%) 0.36
    Earnings Per Share (EPS) 0.03
    EBITDA 0.91
    Effective Tax Rate (%) 34.61
    Particulars JUN 2025 (Values in Cr)
    Revenue 51.01
    Operating Expense 49.23
    Net Profit 1.82
    Net Profit Margin (%) 3.56
    Earnings Per Share (EPS) 0.42
    EBITDA 3.03
    Effective Tax Rate (%) 25.71
    Particulars MAR 2025 (Values in Cr)
    Revenue 57.77
    Operating Expense 54.50
    Net Profit 3.24
    Net Profit Margin (%) 5.60
    Earnings Per Share (EPS) 0.74
    EBITDA 4.47
    Effective Tax Rate (%) 17.60
    Particulars MAR 2026 (Values in Cr)
    Revenue 217.04
    Operating Expense 212.39
    Net Profit 5.55
    Net Profit Margin (%) 2.55
    Earnings Per Share (EPS) 1.02
    EBITDA 10.07
    Effective Tax Rate (%) 26.49
    Particulars MAR 2025 (Values in Cr)
    Revenue 133.36
    Operating Expense 140.24
    Net Profit -2.15
    Net Profit Margin (%) -1.61
    Earnings Per Share (EPS) -0.50
    EBITDA 0.75
    Effective Tax Rate (%) -48.27
    Particulars MAR 2024 (Values in Cr)
    Revenue 182.05
    Operating Expense 192.49
    Net Profit 0.34
    Net Profit Margin (%) 0.18
    Earnings Per Share (EPS) 0.14
    EBITDA 1.27
    Effective Tax Rate (%) 145.33
    Particulars MAR 2023 (Values in Cr)
    Revenue 333.91
    Operating Expense 300.63
    Net Profit 29.00
    Net Profit Margin (%) 8.68
    Earnings Per Share (EPS) 8.91
    EBITDA 39.95
    Effective Tax Rate (%) 23.96
    Particulars MAR 2022 (Values in Cr)
    Revenue 291.52
    Operating Expense 251.76
    Net Profit 27.50
    Net Profit Margin (%) 9.43
    Earnings Per Share (EPS) 16.99
    EBITDA 44.26
    Effective Tax Rate (%) 34.07
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 53.93
    ROE % -1.43
    ROCE % -0.95
    Total Debt to Total Equity 0.42
    EBITDA Margin -0.82
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 54.51
    ROE % -1.71
    ROCE % -1.63
    Total Debt to Total Equity 0.41
    EBITDA Margin -1.05
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 30.86
    ROE % 28.86
    ROCE % 23.73
    Total Debt to Total Equity 0.60
    EBITDA Margin 11.96
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 53.94
    ROE % -1.40
    ROCE % -1.05
    Total Debt to Total Equity 0.25
    EBITDA Margin -0.82
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 54.52
    ROE % -1.70
    ROCE % -1.68
    Total Debt to Total Equity 0.36
    EBITDA Margin -1.05
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 30.86
    ROE % 33.73
    ROCE % 26.00
    Total Debt to Total Equity 0.71
    EBITDA Margin 11.96
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 43.89
    ROE % 34.37
    ROCE % 37.35
    Total Debt to Total Equity 0.39
    EBITDA Margin 15.18
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 84.36
    ROE % 34.53
    ROCE % 54.13
    Total Debt to Total Equity 0.01
    EBITDA Margin 28.19
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 75.99
    Total Assets 400.85
    Total Liabilities 400.85
    Total Equity 234.31
    Share Outstanding 4
    Price to Book Ratio 1.42
    Return on Assets (%) -0.54
    Return on Capital (%) -0.62
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 106.21
    Total Assets 342.68
    Total Liabilities 342.68
    Total Equity 236.86
    Share Outstanding 4
    Price to Book Ratio 2.67
    Return on Assets (%) 0.09
    Return on Capital (%) 0.1
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 1.34
    Total Assets 212.96
    Total Liabilities 212.96
    Total Equity 100.49
    Share Outstanding 3
    Price to Book Ratio 0.00
    Return on Assets (%) 13.61
    Return on Capital (%) 18.14
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 27.33
    Total Assets 317.28
    Total Liabilities 317.28
    Total Equity 234.38
    Share Outstanding 4
    Price to Book Ratio 1.42
    Return on Assets (%) -0.67
    Return on Capital (%) -0.73
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 96.72
    Total Assets 324.72
    Total Liabilities 324.72
    Total Equity 236.88
    Share Outstanding 4
    Price to Book Ratio 2.67
    Return on Assets (%) 0.10
    Return on Capital (%) 0.11
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.45
    Total Assets 212.75
    Total Liabilities 212.75
    Total Equity 100.49
    Share Outstanding 3
    Price to Book Ratio 0.00
    Return on Assets (%) 13.62
    Return on Capital (%) 18.14
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 20.13
    Total Assets 181.81
    Total Liabilities 181.81
    Total Equity 71.46
    Share Outstanding 1
    Price to Book Ratio 0.00
    Return on Assets (%) 15.12
    Return on Capital (%) 20.81
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 18.93
    Total Assets 106.31
    Total Liabilities 106.31
    Total Equity 88.58
    Share Outstanding 1
    Price to Book Ratio 0.00
    Return on Assets (%) 28.77
    Return on Capital (%) 34.4
    Particulars MAR 2025 (Values in Cr)
    Net Income -1.51
    Cash from Operations -1.15
    Cash from Investing -52.76
    Cash from Financing 44.65
    Net change in Cash -6.80
    Free Cash Flow 112.70
    Particulars MAR 2024 (Values in Cr)
    Net Income -0.76
    Cash from Operations 0.90
    Cash from Investing -143.87
    Cash from Financing 152.44
    Net change in Cash 10.45
    Free Cash Flow 46.77
    Particulars MAR 2023 (Values in Cr)
    Net Income 38.13
    Cash from Operations 64.85
    Cash from Investing -55.16
    Cash from Financing -0.93
    Net change in Cash -0.05
    Free Cash Flow 102.53
    Particulars MAR 2025 (Values in Cr)
    Net Income -1.44
    Cash from Operations -25.08
    Cash from Investing 24.97
    Cash from Financing -0.50
    Net change in Cash 2.57
    Free Cash Flow -24.52
    Particulars MAR 2024 (Values in Cr)
    Net Income -0.75
    Cash from Operations 47.80
    Cash from Investing -182.72
    Cash from Financing 135.79
    Net change in Cash 1.85
    Free Cash Flow 51.55
    Particulars MAR 2023 (Values in Cr)
    Net Income 38.13
    Cash from Operations 31.75
    Cash from Investing -21.17
    Cash from Financing -1.53
    Net change in Cash 0.24
    Free Cash Flow 38.82
    Particulars MAR 2022 (Values in Cr)
    Net Income 41.70
    Cash from Operations 16.71
    Cash from Investing -12.23
    Cash from Financing 6.18
    Net change in Cash -3.80
    Free Cash Flow 23.59
    Particulars MAR 2021 (Values in Cr)
    Net Income 47.02
    Cash from Operations 25.56
    Cash from Investing -16.66
    Cash from Financing 11.42
    Net change in Cash 3.86
    Free Cash Flow 27.23
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 30.82 12.79 1.49 236.18 23.12 38.85
    BLISS GVS PHARMA LTD 521.10 41.89 4.63 5526.59 118.35 552.90
    CIPLA LTD. 1438.75 30.53 3.37 116228.74 1165.55 1672.20
    FERMENTA BIOTECH LTD. 411.65 18.16 2.97 1211.53 256.40 415.70
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 30.82 21.55 3.97 236.18 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 540.85 24.24 4.22 1563.63 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8123.85 106.10 23.26 20309.63 7630.00 9850.00
    BLISS GVS PHARMA LTD 521.10 56.34 4.78 5526.59 118.35 552.90

    VALIANT LABORATORIES LTD shareholding pattern

    Holding
    24.86%
    74.93%
    0.19%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    VALIANT LABORATORIES LTD Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    63.75 2.69 redarrow
    red-green-graph indicator
    15 Bearish
    1 Bullish
    • 5 Days 63.30
    • 26 Days 67.20
    • 10 Days 64.40
    • 50 Days 68.50
    • 12 Days 64.80
    • 100 Days 68.70
    • 20 Days 66.30
    • 200 Days 72.30
    62.82 PIVOT
    First Support 61.34 First Resistance 63.64 Second Support 60.52 Second Resistance 65.12 Third Support 59.04 Third Resistance 65.94
    RSI 28.95 ADX 60.11 MACD -2.14 Williams % R -80.17 Commodity Channel Index (CCI) -181.02
    Date [-] Week 0.0 Same Day 0.0 Month 0.0
    1 Year 0.90 3 Year 0.99
    Over 1 Month
    -10.26% down
    Over 1 Year
    -40.85% down
    Over 3 Months
    6.33% down
    Over 3 Years
    -26.77% down
    Over 6 Months
    -4.66% down
    Over 5 Years
    0.00% down

    VALIANT LABORATORIES LTD Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Valiant Laboratories Ltd?

    Answer Field

    Valiant Laboratories Ltd share price is for NSE ₹ 63.75 & for BSE ₹ 63.00 as on Jul 13 2026 03:11 PM.

    What is the Market Cap of Valiant Laboratories Ltd Share?

    Answer Field

    The market cap of Valiant Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 13 2026 03:11 PM.

    What is the 52 Week High and Low of Valiant Laboratories Ltd?

    Answer Field

    The 52 Week High and Low of Valiant Laboratories Ltd for NSE is ₹ 115.05 and ₹ 49.51 and for BSE is ₹ 114.72 and ₹ 50.00.

    What is 1 year return for Valiant Laboratories Ltd?

    Answer Field

    The 1 year returns on the stock has been -40.85%.

    What is the P/E Ratio of Valiant Laboratories Ltd Share?

    Answer Field

    As on Jul 13 2026 03:11 PM the price-to-earnings (PE) ratio for Valiant Laboratories Ltd share is 61.00.

    What is the PB ratio of Valiant Laboratories Ltd Share?

    Answer Field

    As on Jul 13 2026 03:11 PM, the price-to-book (PB) ratio for Valiant Laboratories Ltd share is 58.87.

    How to Buy Valiant Laboratories Ltd Share?

    Answer Field

    You can trade in Valiant Laboratories Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Valiant Laboratories Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Valiant Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Valiant Laboratories Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |